Join the Kineret group to help and get support from people like you.
Kineret News
FDA Approves Kineret (anakinra) for the Treatment of Deficiency of IL-1 Receptor Antagonist (DIRA)
WALTHAM, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) – Sobi™, an international biopharmaceutical company dedicated to rare diseases, announced that the U.S. Food and Drug Administration (FDA) has approved ...
FDA approves Kineret for the treatment of NOMID
Sobi (STO: SOBI) today announced that the US Food and Drug Administration (FDA) has approved Kineret® (anakinra) for the treatment of children and adults with neonatal-onset multisystem inflammatory ...
Further information
Related condition support groups
Rheumatoid Arthritis, COVID-19, Cryopyrin-Associated Periodic Syndromes